Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Not applicable Interventional

Improving Availability of Intranasal Naloxone

ClinicalTrials.gov ID: NCT05877118

Public ClinicalTrials.gov record NCT05877118. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 11:04 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Improving Availability of Intranasal Naloxone Rescue for Opioid Overdose

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

While there is a lifesaving medication called naloxone that can reverse the deadly effects of opioid overdose, patients often fail to fill the prescription at the pharmacy when it is prescribed. This is particularly concerning and true in those at the highest risk of death-those who end up in the emergency department for opioid overdose. The goal of this study is to compare the impact of different overdose education on naloxone prescription fill rates in opioid users being discharged from our hospital emergency department. You will receive either (a) written education about naloxone through their MyChart account, or (b) a concise one-page handout and 4-minute video clip reviewed with the participant and a support individual (family/friend) prior to discharge.

Study identification

NCT ID
NCT05877118
Recruitment status
Not listed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Hartford Hospital
Other
Enrollment
84 participants

Conditions and interventions

Interventions

Behavioral

Eligibility (public fields only)

Age range
21 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 29, 2024
Primary completion
Aug 30, 2025
Completion
Dec 30, 2025
Last update posted
Jun 6, 2024

2024 – 2025

United States locations

U.S. sites
2
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Hartford Hospital Emergency Department Hartford Connecticut 06106 Recruiting
Olin Neuropsychiatry Research Center Hartford Connecticut 06106 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Recently updated Opioid Overdose trials

Other public records listing Opioid Overdose. Sorted by last update posted; newest first. Not a recommendation.

All Opioid Overdose trials →

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05877118, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 6, 2024 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05877118 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →